Literature DB >> 19246975

Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population.

Z L Wang1, B Xia, U Shrestha, L Jiang, C W Ma, Q Chen, H Chen, Z G Hu.   

Abstract

BACKGROUND: To investigate the effect of single nucleotide polymorphisms (SNP) 45 and 276 of the adiponectin gene on non-alcoholic fatty liver disease (NAFLD) with or without metabolic syndrome.
METHODS: A total of 165 NAFLD, 83 NAFLD with metabolic syndrome and 160 healthy controls from Chinese population were genotyped for the adiponectin gene (+45T>G and +276G>T) by PCR-restriction fragment length polymorphism methods. Plasma adiponectin and insulin levels were determined by enzyme-linked immunosorbent assay and radioimmunoassay, respectively. Insulin resistance (IR) was evaluated by using homeostasis model assessment of IR (HOMA-IR).
RESULTS: NAFLD with metabolic syndrome had further extent of IR and hypoadiponectinemia. No association of SNP45 or SNP276 was found in NAFLD or NAFLD with metabolic syndrome. Subjects carrying the G allele of SNP45 showed higher levels of triglyceride (TG), fasting blood sugar (FBS), HOMA, body mass index (BMI), and alanine transaminase (ALT), as well as lower plasma adiponectin levels. In the normal-weight group of SNP276, subjects carrying the G allele showed higher HOMA and subjects carrying the T allele showed lower BMI.
CONCLUSIONS: Our study observed further hypoadiponectinemia and IR in NAFLD with metabolic syndrome. The T45G and G276T of the adiponectin gene may not be the important determinants of NAFLD in Chinese people, but some of them still influence serum ALT, BMI, IR, lipid, glucose metabolism and plasma adiponectin concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19246975     DOI: 10.1007/BF03345657

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  36 in total

1.  The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin.

Authors:  Yangsoo Jang; Jong Ho Lee; Oh Yoen Kim; Soo Jeong Koh; Jey Sook Chae; Jin Hee Woo; Hongkeun Cho; Jong Eun Lee; Jose M Ordovas
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

2.  The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.

Authors:  A Lonardo; M Bellini; P Tartoni; E Tondelli
Journal:  Ital J Gastroenterol Hepatol       Date:  1997-08

3.  Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.

Authors:  Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant
Journal:  Atherosclerosis       Date:  2006-05-08       Impact factor: 5.162

4.  Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver.

Authors:  N Iwamoto; Y Ogawa; S Kajihara; A Hisatomi; T Yasutake; T Yoshimura; T Mizuta; T Hara; I Ozaki; K Yamamoto
Journal:  Clin Chim Acta       Date:  2001-12       Impact factor: 3.786

5.  Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.

Authors:  José L González-Sánchez; María J Martínez-Calatrava; María T Martínez-Larrad; Carina Zabena; Cristina Fernández-Pérez; Markku Laakso; Manuel Serrano-Ríos
Journal:  Clin Chem       Date:  2005-10-27       Impact factor: 8.327

Review 6.  Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.

Authors:  Roger K Schindhelm; Michaela Diamant; Jacqueline M Dekker; Maarten E Tushuizen; Tom Teerlink; Robert J Heine
Journal:  Diabetes Metab Res Rev       Date:  2006 Nov-Dec       Impact factor: 4.876

7.  Genomic structure and mutations in adipose-specific gene, adiponectin.

Authors:  M Takahashi; Y Arita; K Yamagata; Y Matsukawa; K Okutomi; M Horie; I Shimomura; K Hotta; H Kuriyama; S Kihara; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Int J Obes Relat Metab Disord       Date:  2000-07

8.  Association of the human adiponectin gene and insulin resistance.

Authors:  Emanuela Filippi; Federica Sentinelli; Vincenzo Trischitta; Stefano Romeo; Marcello Arca; Frida Leonetti; Umberto Di Mario; Marco Giorgio Baroni
Journal:  Eur J Hum Genet       Date:  2004-03       Impact factor: 4.246

9.  Decreased plasma adiponectin concentrations in women with dyslipidemia.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

Authors:  Claudia Menzaghi; Tonino Ercolino; Rosa Di Paola; Anders H Berg; James H Warram; Philipp E Scherer; Vincenzo Trischitta; Alessandro Doria
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  17 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease.

Authors:  Hong-Jue Li; Chang-Ping Li; Chao Zhang; Xiao-Lin Zhong; Lei Shi
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Adiponectin, a key adipokine in obesity related liver diseases.

Authors:  Christa Buechler; Josef Wanninger; Markus Neumeier
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 4.  Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus.

Authors:  Monisha Banerjee; Madhukar Saxena
Journal:  World J Diabetes       Date:  2014-08-15

5.  The association between adiponectin (+45T/G) and adiponectin receptor-2 (+795G/A) single nucleotide polymorphisms with cirrhosis in Iranian population.

Authors:  Fatemeh Namvaran; Parvaneh Rahimi-Moghaddam; Negar Azarpira; Saman Nikeghbalian
Journal:  Mol Biol Rep       Date:  2011-06-25       Impact factor: 2.316

6.  AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression.

Authors:  Bai-Fang Wang; Ying Wang; Ran Ao; Jing Tong; Bing-Yuan Wang
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

Review 7.  Genetic determinants of hepatic steatosis in man.

Authors:  Amanda J Hooper; Leon A Adams; John R Burnett
Journal:  J Lipid Res       Date:  2011-01-18       Impact factor: 5.922

Review 8.  Genetic variants in candidate genes influencing NAFLD progression.

Authors:  Michelino Di Rosa; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2011-09-06       Impact factor: 4.599

9.  Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions.

Authors:  Jennifer Emily Enns; Carla G Taylor; Peter Zahradka
Journal:  J Obes       Date:  2011-04-19

10.  Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.

Authors:  Ching-Jung Hsieh; Pei Wen Wang; Tsung Hui Hu
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.